Cedars-Sinai Medical Center, Smidt Cedars-Sinai Heart Institute, Los Angeles, California.
Kerckhoff Heart and Thorax Center, Bad Nauheim, Germany.
J Am Coll Cardiol. 2020 Sep 1;76(9):1018-1030. doi: 10.1016/j.jacc.2020.07.005.
Bicuspid aortic stenosis accounts for almost 50% of patients undergoing surgical aortic valve replacement in the younger patients. Expanding the indication of transcatheter aortic valve replacement (TAVR) toward lower-risk and younger populations will lead to increased use of TAVR for patients with bicuspid aortic valve (BAV) stenosis despite the exclusion of bicuspid anatomy in all pivotal clinical trials.
This study sought to evaluate the association of BAV morphology and outcomes of TAVR with the new-generation devices.
Patients with BAV confirmed by central core laboratory computed tomography (CT) analysis were included from the international multicenter BAV TAVR registry. BAV morphology including the number of raphe, calcification grade in raphe, and leaflet calcium volume were assessed with CT analysis in a masked fashion. Primary outcomes were all-cause mortality at 1 and 2 years, and secondary outcomes included 30-day major endpoints and procedural complications.
A total of 1,034 CT-confirmed BAV patients with a mean age of 74.7 years and Society of Thoracic Surgeons score of 3.7% underwent TAVR with contemporary devices (n = 740 with Sapien 3; n = 188 with Evolut R/Pro; n = 106 with others). All-cause 30-day, 1-year, and 2-year mortality was 2.0%, 6.7%, and 12.5%, respectively. Multivariable analysis identified calcified raphe and excess leaflet calcification (defined as more than median calcium volume) as independent predictors of 2-year all-cause mortality. Both calcified raphe plus excess leaflet calcification were found in 269 patients (26.0%), and they had significantly higher 2-year all-cause mortality than those with 1 or none of these morphological features (25.7% vs. 9.5% vs. 5.9%; log-rank p < 0.001). Patients with both morphological features had higher rates of aortic root injury (p < 0.001), moderate-to-severe paravalvular regurgitation (p = 0.002), and 30-day mortality (p = 0.016).
Outcomes of TAVR in bicuspid aortic stenosis depend on valve morphology. Calcified raphe and excess leaflet calcification were associated with increased risk of procedural complications and midterm mortality. (Bicuspid Aortic Valve Stenosis Transcatheter Aortic Valve Replacement Registry; NCT03836521).
在年轻患者中,二叶式主动脉瓣狭窄占接受主动脉瓣置换手术的患者的近 50%。将经导管主动脉瓣置换术(TAVR)的适应证扩大到低危和年轻人群,将导致更多的二叶式主动脉瓣(BAV)狭窄患者接受 TAVR 治疗,尽管所有关键临床试验都排除了二叶式解剖结构。
本研究旨在评估新一代器械与 BAV 形态学和 TAVR 结局的相关性。
从国际多中心 BAV TAVR 注册中心纳入经中心核心实验室计算机断层扫描(CT)分析证实的 BAV 患者。以盲法方式通过 CT 分析评估 BAV 形态,包括隔脊数量、隔脊钙化程度和瓣叶钙体积。主要结局为 1 年和 2 年全因死亡率,次要结局包括 30 天主要终点和手术并发症。
共纳入 1034 例经 CT 证实的 BAV 患者,平均年龄 74.7 岁,胸外科医师协会评分 3.7%,接受了当代器械的 TAVR(n=740 例,采用 Sapien 3;n=188 例,采用 Evolut R/Pro;n=106 例,采用其他器械)。全因 30 天、1 年和 2 年死亡率分别为 2.0%、6.7%和 12.5%。多变量分析确定钙化隔脊和瓣叶过度钙化(定义为钙体积超过中位数)是 2 年全因死亡率的独立预测因素。269 例(26.0%)患者同时存在钙化隔脊和瓣叶过度钙化,其 2 年全因死亡率明显高于仅存在 1 种或无上述形态特征的患者(25.7%比 9.5%比 5.9%;log-rank p<0.001)。同时存在这两种形态特征的患者主动脉根部损伤发生率更高(p<0.001),中重度瓣周漏发生率更高(p=0.002),30 天死亡率也更高(p=0.016)。
二叶式主动脉瓣狭窄 TAVR 的结局取决于瓣膜形态。钙化隔脊和瓣叶过度钙化与手术并发症和中期死亡率增加相关。(二叶式主动脉瓣狭窄经导管主动脉瓣置换注册研究;NCT03836521)